Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
Active, not recruiting · NCT03531645 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma | Malignant Neoplasms of Female Genital Organs | Active, not recruiting | Phase 2 | 2026-09-14 | NCT03531645 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Eli Lilly and Company | 370 |
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |